Menu Search
Equities

Spexis AG

29Y:BRN

Spexis AG

Actions
  • Price (CHF)0.062
  • Today's Change0.00 / 0.00%
  • Shares traded25.27k
  • 1 Year change--
  • Beta--
Data delayed at least 15 minutes, as of Jul 22 2024.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Inc stmt in CHFIncome statement in CHFView more

Year on year Spexis AG's net income fell 5.75% from a loss of 18.55m to a larger loss of 19.62m despite flat revenues.
Gross margin--
Net profit margin--
Operating margin--
Return on assets-84.79%
Return on equity-242.47%
Return on investment-149.58%
More ▼

Cash flow in CHFView more

In 2023, cash reserves at Spexis AG fell by 1.29m. Cash Flow from Financing totalled 4.35m or -- of revenues. In addition the company used 5.48m for operations while cash from investing was breakeven.
Cash flow per share-0.3532
Price/Cash flow per share--
Book value per share-0.0546
Tangible book value per share-0.1216
More ▼

Balance sheet in CHFView more

Spexis AG has a Debt to Total Capital ratio of 168.97%, a higher figure than the previous year's 23.44%.
Current ratio0.7883
Quick ratio--
Total debt/total equity--
Total debt/total capital1.69
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.